Member Info for lospeculatore

Correct, the USA has been main target since inception, but doesn't mean the European market isn't there to more than balance any fragility in US markets. Imagine a nice fat NHS contract.

I wish people on all forums would read other threads before posting - see Testudo 12/07. He's done all the relevant research.

Someone else made a case for Bracco takeover the other day. Interesting that they preferred to double their stake in the company with that $2 million investment. Tells us The Board aren't interested in a sale at this stage and Bracco definitely think it's going places. So think of a bidding war with Phillips.

What about the 18% oversubscription and the current holders who will have failed to get the full amount they applied for?

It won't be under 1p for very long.

You.ve hit it right on the head Shpunken.

400,000,000 not actually a lot of 1p shares.

Sure the day traders will play games but when you price in the number of lths who will average down and hold and the very real possibility of a new sale this is going only one way.

Think a lot of holders have realised that they’re not going to get anything more than max 10% extra placing shares and buying them before too late. Me included ;)

Of course he couldn't.

Xenon takes a lot of stick on here but he speaks for everyone trapped on 25p+ or even in teens. I'd be p@ssed about it. Luckily I got in late and on 4p at moment.

But this is AIM. It's high risk. We've all been there and you just have to take it on the chin and move on.

I think he's right, those people will use the issue as an excuse to cut their losses and get out.

But others will carry on averaging down. Don't see it as a big problem.

From today’s circular:

Further details of the Open Offer and the terms and conditions on which it is being made, including the procedure for application and payment, will be contained in the Circular, extracts of which were contained in the announcement on 21 May 2024 and which is expected to be posted to Shareholders later today. The Circular will also be available on the Company's website later today: https://www.polarean-ir.com/content/investors/shareholder-information.

If you don’t subscribe to investor info keep your eyes on the website this afters.

Unfortunately I've already added to the hilt!

Well done all lth and to those who kept their nerve.

Its a windup - right?

Who did? Why can't you divulge?

Strange, though, that there is no mention of Polarean on his cv?

What I like is this isn't any old hospital. This is the top-ranked children's hospital in the US. So they're setting a precedent and more will surely follow.

One thing I'd love to know. What is the significance of the word upgraded? What is included in this piece of equipment that wasn't in the reasearch polariser?

It’s an order, not a gift.

DJ you’re clearly not invested here with your ‘well a company web site ..enough said’.

Any misrepresentation of information on the website would be fraud and a very serious worry for any investors.

Or rather Duke are the assignee for the patent. Not quite the same thing. Polarean are still inventors of the patented tech.

Your right, Duke own the patent but Polarean have a licensing agreement with exclusive rights to use of the technology.

See company website.

Https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/11944424

for anyone who wants to see it in full.

Most of the physics is beyond me! But two things struck me. The number of clinical trials already completed and how far back they go e.g early 2000s.

As Chris keeps saying - it takes time with developments like this. But we can clearly see now that Polarean has a lead position in the field that won't go unnoticed for long.

JJ7 - are you an insider by any chance?

Great layman's explanation of the the gas exchange process for new and old investors alike.

Https://www.frontiersin.org/articles/10.3389/fmed.2024.1342499/full

just released research results just coming out of Duke University.

Good to see Bastiaan getting his hands dirty and publishing stuff that will have an impact on raising awareness in the field.

Jimzi - those were goldrush shares. Sadly, it's what AIM is largely about.

We have a proven product here with a usp and patents, sales already in and clinical trials across north america and western europe. UK NHS Trusts wouldn't be trialling this if they didn't think there was some mileage in it.